Investment Summary

Refeyn (originally named Arago Biosciences) is a spin-out company from the University of Oxford’s Department of Chemistry. The company has designed a new way of detecting and quantifying molecules. The patent-protected technology allows users to carry out label-free imaging, localisation, and accurate mass determination of single biomolecules in solution. The approach has the potential to revolutionise the characterisation of molecular interactions, making it particularly relevant to the pharmaceutical, biomedical and research sectors.